MLB, MLBPA agree to enhance joint drug program
http://0rz.tw/OFBNG
More frequent testing, increased suspensions part of new agreement
By Paul Hagen / MLB.com | 3/28/2014 7:51 P.M. ET
Major League Baseball and the Major League Baseball Players Association agreed
Friday on significant enhancements to the Joint Drug Prevention and Treatment
Program, including more frequent testing and harsher penalties for players who
intentionally use performance-enhancing substances.
The changes are the most extensive since 2006 and come just more than a year
after MLB and the MLBPA added blood testing for human growth hormone, extended
testing to the offseason and established a baseline for testosterone levels at
the Owners Meetings in January 2013.
"Although we had the strongest program in professional sports before these
changes, I am committed to constantly finding ways to improve the program in
order to eradicate performance-enhancing drugs from the game and for MLB to
serve as a model for other drug programs," Commissioner Bud Selig said in a
statement. "I want to express my appreciation to the players for being
proactive and showing remarkable leadership in producing the new agreement. I
commend them for both their foresight and their creativity throughout this
process, and for strongly sharing our desire to improve what is already the
toughest drug program in sports."
Said Tony Clark, executive director of the Players Association: "Experience
proves that increased penalties alone are not sufficient; that's why the players
pushed for a dramatic increase in the frequency and sophistication of our tests
, as well as comprehensive changes in a number of other areas of the program
that will serve as a deterrent. Make no mistake, this agreement underscores the
undisputed reality that the players put forward many of the most significant
changes reached in these negotiations because they want a fair and clean game."
The revisions address three primary areas:
INCREASED TESTING
Beginning immediately, the number of in-season random urine collections will
more than double from 1,400 to 3,200 and the frequency of offseason collections
has been raised from 250 to 350. That's in addition to the mandatory tests that
every player undergoes during Spring Training and the regular season.
Blood collections for HGH detection, already the most thorough in American
professional sports, will increase to 400 both in and out of season. Again,
that's in addition to the 1,200 samples taken in Spring Training.
Any player who's suspended for violating the program will be subject to six
additional urine tests and three additional blood tests per season for the rest
of his career.
The list of banned substances has been expanded. Use of DHEA in 2014 will
result in follow-up testing for a first violation; a 25-game suspension for a
second violation; an 80-game suspension for a third violation; and up to a
permanent suspension for a fourth violation. MLB and the MLBPA are still
finalizing other additions to the prohibited substance list, which are expected
to be completed by next week.
Carbon Isotope Ratio Mass Spectrometry (IRMS) will be randomly performed on at
least one specimen from every player in addition to any IRMS test that the
Montreal laboratory conducts as a result of the parties' longitudinal profiling
program (which was implemented prior to the 2013 season) and the World
Anti-Doping Agency (WADA) guidelines for conducting IRMS.
PENALTIES
A first-time offender will receive an 80-game suspension, up from the previous
50 games. A second violation will result in a 162-game suspension and a loss of
an entire season (183 days) of pay, up from 100 games. A third violation will
lead to permanent banishment.
Any player disciplined for a violation involving performance-enhancing
substances will not be allowed to participate in the postseason and will not be
eligible for an automatic playoff share.
PLAYER BENEFITS
The Arbitration Panel has been given the right to reduce a player's suspension
if he proves at a hearing that the use was not intended to improve his
performance.
The panel may not reduce the first-time penalty to fewer than 40 games, the
second offense to fewer than 80 games or change the permanent suspension for a
third-time violator at all. The panel will have no authority to reduce a
penalty if the positive test result was for testosterone; human growth hormone
(HGH); gonadotropins; selective estrogen receptor modulators; anti-estrogens,
boldenone; nandrolone; and stanozolol.
A program has been established which will give players year-round access to
supplements that will not cause positive test results as well as additional
technological resources to provide information regarding supplements and
prescription or over-the-counter medications.
Improvements will be made in both home and visitor's weight rooms based on
recommendations by a joint committee chaired by Tim Maxey, the Joint Strength
and Conditioning Coordinator.
The confidentiality provisions of the program also have been strengthened.
简译：
季中尿液收集样本数量将增加至3200个，
过去只有1400个。
季后赛也将从250增加到350个，
这是除了春训至正规赛季的强制性采样以外多增加的数目。
原本官方为检测HGH而采的血液样本已经是美国所有职业运动中最多的。
这次季中与季外将增至400个，
也是除了春训期间采的1200个样本之外多增加的。
（HGH：人类生长激素）
被抓包过的球员往后职业生涯将被额外多测六种尿液与三种血液检测。
禁用药物也增加。
2014年开始，
使用DHEA被抓第一次会追加后续测试，
第二次禁25场，
第三次禁80场，
第四次终身禁赛。
其它追加药种还在审核中预计下周公布完整清单。
关于禁赛场次方面第一次会从过去50场追加到80场，
第二次从100场加到162场，
也包括整个球季的登录天数183天都无法领到薪水。
（应该是针对A-Rod今年还是凹到3M而补洞）
第三次终身禁赛。
任何因牵涉禁药遭到禁赛的球员将不被允许参加季后赛，
也无法支领季后赛分红。
如果球员能证明自己非故意使用增强表现的药物，
仲裁庭也给予他减刑的权利。
但仲裁庭没有权限减少因以下几种药物而生的处分：
testosterone
human growth hormone
gonadotropins
selective estrogen receptor modulators
anti-estrogens
boldenone
nandrolone
stanozolol
球员将得到整年的时间补充额外的技术性资料以及提供资讯，
说明自己所用的处方或非处方药物并不会导致阳性反应。